MY Health Care Blog

  The   dermal fillers market size   is anticipated to grow at a 2.9% CAGR between forecast period. They are employed to rejuvenate various facial regions linked to specific functions. The market is expanding as a result of the increased demand for facelifts and face line corrections in various emerging nations. As businesses concentrate on creating variations of products that are already on the market, the global dermal fillers industry is transitioning from a growth period to maturity. This recent study from Future Market Insights addresses the intense pricing rivalry, company-to-company discounts, and physician practises that tend to raise margins and impede patient acceptance of the dermal filler process around the world. The proliferation of aesthetic surgeons and the variety of uses for dermal fillers are the primary drivers of the global dermal fillers market's expansion. Dermal fillers are effective in treating conditions including acne scars, enhancing the dorsal...

  The   downstream processing market size   is anticipated to grow at a CAGR of 11.3% between 2022 and 2032, reaching a market valuation of US$ 72.3 Bn by the end of 2032. The global downstream processing market size was valued at US$ 22.0 Bn in 2021 and is anticipated to enjoy a valuation of US$ 24.9 Bn by the end of 2022. Downstream processing is used to manufacture antibiotics, antibodies, hormones, vaccines and also used for the production of industrial enzymes. In  downstream processing , the purification and recovery of biosynthetic products is done that are derived from natural sources such as tissues of animals and plants. The downstream processing market demand is fuelled by the ever growing demand for biopharmaceuticals and increasing R&D spending on the development of such products. However, the high cost of the instruments involved in downstream processing and a dearth of skilled workforce is hampering the growth of this market. Forecast Highligh...

  Global  laboratory information system (LIS) market   revenues are set to grow at 10.2% CAGR through 2030, according to an updated edition by Future Market Insights (FMI). The 2022-2030 version of the report builds upon the widely cited previous version, and incorporates the latest developments, notably, the impact of COVID-19 pandemic on this market. Massive technical improvements in the healthcare sector over time have included automation, big data analytics, and cloud computing. The necessity to balance administrative and caring activities is the most crucial factor in the sector. Thanks to the development of sophisticated laboratory testing technologies, this is now achievable. The cornerstone of managing primary healthcare is laboratories. Drug development and the creation of APIs take place in laboratories. It is necessary to streamline repetitive tasks like data collection, assimilation, and record maintenance in order to increase the speed at which these processe...

 The  Insulin Pumps Market  revenues were estimated at  US$ 5.5 Bn in 2022  and is anticipated to grow at a CAGR of  10.3%  from 2022-2032, according to a recently published Future Market Insights report. By the end of 2032, the market is expected to reach  US$ 14.8 Bn . The demand for tethered pumps is projected to garner an absolute dollar opportunity of US$ 6.7 Bn during 2022 – 2032. One of the reasons driving market expansion is an increase in the incidence of diabetes owing to age, obesity, and an unhealthy lifestyle. Obesity is a primary cause of diabetes, which leads to a rise in the prevalence of diabetes-related ocular illnesses. In 2017, the worldwide incidence of diabetes was estimated to be about 22.9 million, the prevalence was reported to be around 476 million, 1.37 million fatalities were recorded owing to diabetes, and 1.37 million disability-adjusted life-years (DALYs) were reported to be related to diabetes. According to the WHO,...

  According to a recent study done by FMI, the  Micropump market  is expected to reach US$ 9.27 billion by 2032, up from US$ 1.6 billion in 2021, expanding at a high CAGR of 19%. This study explains how the micropump market is directly proportional to increasing technological advancements and rising demand for micropumps during care testing. The micropumps include micropump gj, micropump ga, etc. The rising awareness and importance of controlled drug delivery are helping the market rise up. Also, increasing demand for miniatured medical devices is helping the global micropump market grow excessively. The use of  micropumps  in nasal and pulmonary routes drug delivery is another driving factor for the global market as awareness also increases around control drug delivery in order to gain a positive impact. Micropumps like waterway micropump, cole parmer micropumpsare used to help the accurate drug delivery processes.  The rising appl...

  The  pharmaceutical drug delivery market  was worth US$ 1600 billion in 2021 and is predicted to grow to US$ 3000 billion by 2032, a CAGR of 6% during the forecast period. “ The growing incidence of infectious diseases globally, expanding R&D expenditure for innovative medicines, and rising FDA approvals all contribute to the expansion of this market category .” The increased prevalence of chronic diseases, the developing biologics industry, extensive R&D investments, and technological innovations & new product launches are all contributing to the rise in the pharmaceutical drug delivery industry. Pharmaceutical drug delivery device  has certain advantages, including ease of use, efficiency, and patient compliance. As a result, drug developers are concentrating on appropriate delivery and packaging alternatives to increase treatment efficiency and provide enhanced patient compliance. The pharmaceutical drug delivery market trends and...

  According to a recent study by Future Market Insights (FMI), the global  Bioprocess Technology Market  was valued at US$ 17.3 Bn in 2020 and is expected to register a CAGR of 15.2% during the forecast period (2021-2031). It is projected to generate a revenue of US$ 81.2 Bn by the end of 2031. Technology has always been at the heart of  biotech . The emergence of advanced computing technology such as machine learning and artificial intelligence has enabled companies to expand the scale of their research and improve efficiency in the manufacturing process—both of which reduce the time it takes for biotech firms to bring new products to market. Increasing research and development spending on pharmaceutical products has improved the well-being of patients to a significant level. Today vaccines have proven to be one of the most effective ways to prevent children from infectious diseases. This is highly possible due to increased government spending on research & deve...